Case Report


Lactobacillus acidophilus bacteremia in a diabetic patient

,  ,  

1 Senior Resident, Department of Medicine, Saint Mary’s Hospital, Waterbury, Connecticut, USA

2 Resident, Department of Medicine, Saint Mary’s Hospital, Waterbury, Connecticut, USA

3 Department of Infectious Diseases, Saint Mary’s Hospital, Waterbury, Connecticut, USA

Address correspondence to:

Ahmad Nawid Latifi

56 Franklin Street, Waterbury, Connecticut 06706,

USA

Message to Corresponding Author


Article ID: 100005Z16AL2019

doi: 10.5348/100005Z16AL2019CR

Access full text article on other devices

Access PDF of article on other devices

How to cite this article

Latifi AN, Saeyeldin A, Simms M. Lactobacillus acidophilus bacteremia in a diabetic patient. J Case Rep Images Infect Dis 2019;2:100005Z16AL2019.

ABSTRACT


Introduction: Lactobacilli are part of the normal gastrointestinal and genitourinary microbiota. They are generally considered nonpathogenic and rarely cause serious infections.

Case Report: We present the case of a 46-year-old woman with poorly controlled diabetes mellitus, who was found to have Lactobacillus acidophilus bacteremia and urinary tract infection (UTI). She was treated with penicillin with resolution of her bacteremia and UTI.

Conclusion: This case highlights the potential pathogenicity of these organisms in immunocompromised patients. Appropriate treatment is required to avoid potential life-threatening complications.

Keywords: Bacteremia, Diabetes, Lactobacillus, Probiotics

Introduction


Lactobacilli are facultative, anaerobic, nonspore forming Gram positive rods that ferment to yield lactic acid. They are part of the normal flora of the oropharynx, gastrointestinal tract, and the female genital tract [1]. They are generally considered nonpathogenic organisms, and some strains are used as probiotics. However, there are reported cases of serious infections due to lactobacilli species such as bacteremia [2]. Risk factors for lactobacillus infection are impaired immune response states such as diabetes mellitus (DM), hematologic malignancies, total parenteral nutrition, organ transplantation, human immunodeficiency virus (HIV) infection, steroid use, and administration of probiotics [3],[4],[5],[6]. We herein present the case of a 46-year-old woman with poorly controlled DM, who was found to have L. acidophilus urinary tract infection (UTI) and bacteremia.

Case Report


A 46-year-old morbidly obese woman, with poorly controlled type 2 diabetes mellitus (DM), prior history of transient ischemic attacks (TIAs) related to drug use, current smoker, with a history of polysubstance abuse (including alcohol and cocaine), who presented to emergency department with complaints of abdominal pain and vomiting of four days duration. Review of systems was positive for urinary frequency, dysuria, and heartburn. The patient was not complaint with her medications, including her insulin.

On physical examination she was afebrile, with blood pressure of 153/64 mmHg, heart rate of 82 beats/min, and respiratory rate of 22 breaths/min. She appeared dehydrated and lethargic. Her abdominal examination was notable for epigastric tenderness without rigidity or guarding. Laboratory workup demonstrated leukocytosis of 14,200 with 91% neutrophils, blood glucose of 782 mg/dL, HbA1c of 12.2, high anion-gap metabolic acidosis with positive ketones in the urine, and negative human immunodeficiency virus (HIV) serology. The patient was treated for diabetic ketoacidosis (DKA) with intravenous insulin infusion, intravenous fluid, and close monitoring of electrolytes and vitals. The Gram stain of positive blood cultures showed gram positive bacilli (Figure 1), and she was started empirically on intravenous ceftazidime and vancomycin. The organism later identified to be L. acidophilus using RapID CB Plus system. Urine culture also revealed 10,000–20,000 colony-forming unit/mL of Lactobacillus species, however, further strain specification was not performed, and it was presumed to be the same species as the blood culture. The antimicrobial regimen was changed to intravenous penicillin G. Subsequently, the DKA was resolved and intravenous insulin was switched to subcutaneous insulin. During hospitalization, the patient continued to complain of epigastric pain. She subsequently underwent Esophagogastroduodenoscopy (EGD), which showed a nonbleeding duodenal ulcer, as well as Los Angeles (LA) grade D esophagitis (Figure 2), and biopsies were obtained. Gram staining of the esophageal brush showed many neutrophils, moderate yeast, moderate gram positive cocci, and few gram negative rods consistent with normal pharyngeal flora. Biopsies from the stomach and duodenum demonstrated acute inflammation, and they were negative for malignancy. Fluconazole was added to her medication regimen for treatment of candidal esophagitis. Of note, the patient’s HIV screening was negative. Over the course of hospitalization, the patient remained afebrile, urinary symptoms improved, and leukocytosis resolved. The repeat blood cultures after starting antibiotics showed no growth. The patient was discharged to a short-term rehab facility on oral amoxicillin to complete a total of 10 days of antibiotics.

Figure 1: Blood cultures grew gram positive bacilli identified as Lactobacillus acidophilus.

Share Image:

Figure 2: Upper endoscopic picture of the lower third of the esophagus. Note the mucosal breaks consistent with LA grade D esophagitis.

Share Image:

Discussion


Members of the Lactobacillus bacteria are normal commensals of the oropharynx, gastrointestinal tract, and the female genital tract. Lactobacilli are often considered commensal or beneficial participants in human microbial ecology, and their use as probiotics is aimed at restoring normal bacterial microflora and to decrease colonization with pathogenic bacteria. Systemic infections with lactobacilli are generally uncommon. However, Lactobacillus is becoming a potential emerging pathogen, with multiple reports showing life threatening disease including infective endocarditis [7], liver abscess [8], pulmonary infections [9], pyelonephritis [10], meningitis [11], and necrotizing fasciitis [12]

The reported risk factors are immunocompromised states such as DM, malignancy, organ transplantation, and short gut syndrome [13]. Lactobacillus bacteremia might be underdiagnosed because lactobacilli are cumbersome to culture and to identify, and in many cases they have been regarded as contaminants [1] given it ubiquitous presence in normal human flora.

Our patient had a very poorly controlled DM (HbA1c of 12.2) due to noncompliance with her insulin, predisposing her to DKA and to opportunistic infection, including candidal esophagitis and Lactobacillus bacteremia. The potential pathogenicity of lactobacilli is likely due to a translocation mechanism by which some strains bind to mucosa with the ability to adhere to extracellular matrix proteins, producing glycosidase and proteases enzymes, which help breakdown the glycoproteins of affected tissues [14],[15],[16].

Some strains have shown resistance to intracellular killing by macrophages, and to the bactericidal effects of nitric oxide as well [17]. There are reports of lactobacillus infection after probiotic administration, which is concerning given their wide use [13],[18]. In case reports of bacteremia, several Lactobacillus species have been identified, but the two most common species were Lactobacillus casei and Lactobacillus rhamnosus—both of which are common in probiotic use [19]. A recent systemic review of the safety of probiotics in 2010—including 53 trials—in which 4131 patients received probiotics. Only three trials showed increased complications, which were mostly in transplant patients [20]. In our case the patient denied intake of probiotics in the past.

Transient Lactobacillus bacteremia following endoscopy has also been described, mostly with L. rhamnosus [21],[22]. However, this patient’s endoscopy was done after the diagnosis of bacteremia. Urinary tract infections is rarely caused by Lactobacillus species. In fact, reports have suggested the use of lactobacilli species for prevention of recurrent UTI in women, with L. rhamnosus GR1 and Lactobacillus reuteri RC14 being the most studied strains [23]. One case of pyelonephritis caused by Lactobacillus jensenii in a patient with urolithiasis was noted [10], however, L. acidophilus was not encountered. In our patient, the strain of the lactobacilli causing her UTI was not specified, however, blood cultures grew L. acidophilus.

Antibiotic susceptibility of Lactobacillus species is variable, with studies showing susceptibility of these microbes to ampicillin, clindamycin, erythromycin, and gentamicin, with high resistance to vancomycin, albeit there is paucity of evidence regarding the best antibiotic regimen [2],24],[25]. Our patient was treated with vancomycin and ceftazidime initially, and later switched to penicillin with resolution of the bacteremia and the urinary symptoms. The studies to demonstrate the preferred choice of antibiotics for lactobacilli infection are lacking due to rarity of clinically significant infection, however, treatment with beta lactams, fluoroquinolones, carbapenems, gentamicin, and clindamycin have been shown to be effective [2].

Conclusion


In conclusion, this case illustrates that L. acidophilus can cause life-threatening disease in an immunocompromised host. A wide array of complications reported in literature include infective endocarditis, bacteremia, liver abscesses, and necrotizing fasciitis. Lactobacillus in microbiological cultures should not be ignored as contaminants in this patient population. Patients with risk factors who predispose to opportunistic infections should avoid taking probiotics.

REFERENCES


1.

Aguirre M, Collins MD. Lactic acid bacteria and human clinical infection. J Appl Bacteriol 1993;75(2):95–107. [CrossRef] [Pubmed]   Back to citation no. 1  

2.

Salminen MK, Rautelin H, Tynkkynen S, et al. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis 2004;38(1):62–9. [CrossRef] [Pubmed]   Back to citation no. 1  

3.

Horwitch CA, Furseth HA, Larson AM, Jones TL, Olliffe JF, Spach DH. Lactobacillemia in three patients with AIDS. Clin Infect Dis 1995;21(6):1460–2. [CrossRef] [Pubmed]   Back to citation no. 1  

4.

Schlegel L, Lemerle S, Geslin P. Lactobacillus species as opportunistic pathogens in immunocompromised patients. Eur J Clin Microbiol Infect Dis 1998;17(12):887–8. [CrossRef] [Pubmed]   Back to citation no. 1  

5.

Antony SJ, Stratton CW, Dummer JS. Lactobacillus bacteremia: Description of the clinical course in adult patients without endocarditis. Clin Infect Dis 1996;23(4):773–8. [CrossRef] [Pubmed]   Back to citation no. 1  

6.

Cooper CD, Vincent A, Greene JN, Sandin RL, Cobian L. Lactobacillus bacteremia in febrile neutropenic patients in a cancer hospital. Clin Infect Dis 1998;26(5):1247–8. [CrossRef] [Pubmed]   Back to citation no. 1  

7.

Husni RN, Gordon SM, Washington JA, Longworth DL. Lactobacillus bacteremia and endocarditis: Review of 45 cases. Clin Infect Dis 1997;25(5):1048–55. [CrossRef] [Pubmed]   Back to citation no. 1  

8.

Sherid M, Samo S, Sulaiman S, Husein H, Sifuentes H, Sridhar S. Liver abscess and bacteremia caused by lactobacillus: Role of probiotics? Case report and review of the literature. BMC Gastroenterol 2016;16(1):138. [CrossRef] [Pubmed]   Back to citation no. 1  

9.

Datta P, Gupta V, Mohi GK, Chander J, Janmeja AK. Lactobacillus coryniformis causing pulmonary infection in a patient with metastatic small cell carcinoma: Case report and review of literature on Lactobacillus pleuro-pulmonary infections. J Clin Diagn Res 2017;11(2):DE01–5. [CrossRef] [Pubmed]   Back to citation no. 1  

10.

Chazan B, Raz R, Shental Y, Sprecher H, Colodner R. Bacteremia and pyelonephritis caused by Lactobacillus jensenii in a patient with urolithiasis. Isr Med Assoc J 2008;10(2):164–5. [Pubmed]   Back to citation no. 1  

11.

Robin F, Paillard C, Marchandin H, Demeocq F, Bonnet R, Hennequin C. Lactobacillus rhamnosus meningitis following recurrent episodes of bacteremia in a child undergoing allogeneic hematopoietic stem cell transplantation. J Clin Microbiol 2010;48(11):4317–9. [CrossRef] [Pubmed]   Back to citation no. 1  

12.

Hubbard J, Jariwala B, Hill A, Gega A, Palesty JA. A New Bacterium, Lactobacillus acidophilus, Causing Necrotizing Fasciitis. Am Surg 2018;84(2):e61–3. [Pubmed]   Back to citation no. 1  

13.

Kunz AN, Noel JM, Fairchok MP. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 2004;38(4):457–8. [CrossRef] [Pubmed]   Back to citation no. 1  

14.

Apostolou E, Kirjavainen PV, Saxelin M, et al. Good adhesion properties of probiotics: A potential risk for bacteremia? FEMS Immunol Med Microbiol 2001;31(1):35–9. [CrossRef] [Pubmed]   Back to citation no. 1  

15.

Oakey HJ, Harty DW, Knox KW. Enzyme production by lactobacilli and the potential link with infective endocarditis. J Appl Bacteriol 1995;78(2):142–8. [CrossRef] [Pubmed]   Back to citation no. 1  

16.

Naaber P, Smidt I, Tamme K, et al. Translocation of indigenous microflora in an experimental model of sepsis. J Med Microbiol 2000;49(5):431–9. [CrossRef] [Pubmed]   Back to citation no. 1  

17.

Asahara T, Takahashi M, Nomoto K, et al. Assessment of safety of lactobacillus strains based on resistance to host innate defense mechanisms. Clin Diagn Lab Immunol 2003;10(1):169–73. [CrossRef] [Pubmed]   Back to citation no. 1  

18.

Ledoux D, Labombardi VJ, Karter D. Lactobacillus acidophilus bacteraemia after use of a probiotic in a patient with AIDS and Hodgkin's disease. Int J STD AIDS 2006;17(4):280–2. [CrossRef] [Pubmed]   Back to citation no. 1  

19.

Salminen MK, Tynkkynen S, Rautelin H, et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 2002;35(10):1155–60. [CrossRef] [Pubmed]   Back to citation no. 1  

20.

Whelan K, Myers CE. Safety of probiotics in patients receiving nutritional support: A systematic review of case reports, randomized controlled trials, and nonrandomized trials. Am J Clin Nutr 2010;91(3):687–703. [CrossRef] [Pubmed]   Back to citation no. 1  

21.

Avlami A, Kordossis T, Vrizidis N, Sipsas NV. Lactobacillus rhamnosus endocarditis complicating colonoscopy. J Infect 2001;42(4):283–5. [CrossRef] [Pubmed]   Back to citation no. 1  

22.

Baltch AL, Buhac I, Agrawal A, O'Connor P, Bram M, Malatino E. Bacteremia after upper gastrointestinal endoscopy. Arch Intern Med 1977;137(5):594–7. [CrossRef] [Pubmed]   Back to citation no. 1  

23.

Ng QX, Peters C, Venkatanarayanan N, Goh YY, Ho CYX, Yeo WS. Use of Lactobacillus spp. to prevent recurrent urinary tract infections in females. Med Hypotheses 2018;114:49–54. [CrossRef] [Pubmed]   Back to citation no. 1  

24.

Griffiths JK, Daly JS, Dodge RA. Two cases of endocarditis due to Lactobacillus species: Antimicrobial susceptibility, review, and discussion of therapy. Clin Infect Dis 1992;15(2):250–5. [CrossRef] [Pubmed]   Back to citation no. 1  

25.

Sussman JI, Baron EJ, Goldberg SM, Kaplan MH, Pizzarello RA. Clinical manifestations and therapy of Lactobacillus endocarditis: Report of a case and review of the literature. Rev Infect Dis 1986;8(5):771–6. [CrossRef] [Pubmed]   Back to citation no. 1  

SUPPORTING INFORMATION


Author Contributions

Ayman Saeyeldin - Conception of the work, Design of the work, Acquisition of data, Analysis of data, Drafting the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Ahmad Nawid Latifi - Conception of the work, Design of the work, Acquisition of data, Analysis of data, Drafting the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Michael Simms - Conception of the work, Design of the work, Acquisition of data, Analysis of data, Drafting the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Guaranter of Submission

The corresponding author is the guarantor of submission.

Source of Support

None

Consent Statement

Written informed consent was obtained from the patient for publication of this article.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Conflict of Interest

Authors declare no conflict of interest.

Copyright

© 2019 Ahmad Nawid Latifi et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.